Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Baptist Gallwitz

Showing results (51-60 of 126) with videos related to

Pageof 13
Sort By:
Diabetes Care|July 25, 2013
How do we continue treatment in patients with type 2 diabetes when therapeutic goals are not reached with oral antidiabetes agents and lifestyle? Incretin versus insulin treatmentBaptist Gallwitz, Reinhard G Bretzel
Frontiers in Endocrinology|October 11, 2021
Editorial: Reviews and Novel Clinical Perspectives on Semaglutide: A GLP-1 Receptor Agonist With Both Injectable and Oral FormulationsJuris J Meier, Baptist Gallwitz, Francesco Giorgino
Pharmazie in Unserer Zeit|March 3, 2010
[Importance of GLP-1 for glucose homeostasis. Discovery of incretin]Henning Blume, Ralph-Steven Wedemeyer, Baptist Gallwitz
Lancet (London, England)|January 15, 2013
Preregistration of study design and non-inferiority margin - Authors' replyBaptist Gallwitz, Julio Rosenstock, Hans-Juergen Woerle
Deutsche Medizinische Wochenschrift (1946)|November 20, 2015
[Can water be poisonous?]Ferruh Artunc, Günter Schnauder, Baptist Gallwitz, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|March 19, 2003
Glucagon-like peptide 1 and gastric inhibitory polypeptide: potential applications in type 2 diabetes mellitusJuris J Meier, Baptist Gallwitz, Michael A Nauck
Deutsche Medizinische Wochenschrift (1946)|June 18, 2015
[Cardiovascular outcome trials in type 2 diabetes and the sulphonylurea controversy: Rationale for the active-comparator CAROLINA® trial]Baptist Gallwitz, Sandra Thiemann, Hans-Jürgen Wörle, et al.
The Journal of Maternal-Fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians|October 6, 2005
Pheochromocytoma in a patient with sickle-beta-thalassemiaKarsten Müssig, Marius Horger, Hans-Ulrich Häring, et al.
Acta Diabetologica|August 24, 2011
Contribution of insulin deficiency and insulin resistance to the development of type 2 diabetes: nature of early stage diabetesBaptist Gallwitz, Christof Kazda, Petra Kraus, et al.
Clinical Endocrinology|July 27, 2004
Manifestation of thyroid autoimmunity in patients successfully treated for hypercortisolismKarsten Müssig, Baptist Gallwitz, Hans-Ulrich Häring, et al.
Pageof 13

Showing results (51-60 of 126) with videos related to

Sort By:
Pageof 13
Diabetes Care|July 25, 2013
How do we continue treatment in patients with type 2 diabetes when therapeutic goals are not reached with oral antidiabetes agents and lifestyle? Incretin versus insulin treatmentBaptist Gallwitz, Reinhard G Bretzel
Frontiers in Endocrinology|October 11, 2021
Editorial: Reviews and Novel Clinical Perspectives on Semaglutide: A GLP-1 Receptor Agonist With Both Injectable and Oral FormulationsJuris J Meier, Baptist Gallwitz, Francesco Giorgino
Pharmazie in Unserer Zeit|March 3, 2010
[Importance of GLP-1 for glucose homeostasis. Discovery of incretin]Henning Blume, Ralph-Steven Wedemeyer, Baptist Gallwitz
Lancet (London, England)|January 15, 2013
Preregistration of study design and non-inferiority margin - Authors' replyBaptist Gallwitz, Julio Rosenstock, Hans-Juergen Woerle
Deutsche Medizinische Wochenschrift (1946)|November 20, 2015
[Can water be poisonous?]Ferruh Artunc, Günter Schnauder, Baptist Gallwitz, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|March 19, 2003
Glucagon-like peptide 1 and gastric inhibitory polypeptide: potential applications in type 2 diabetes mellitusJuris J Meier, Baptist Gallwitz, Michael A Nauck
Deutsche Medizinische Wochenschrift (1946)|June 18, 2015
[Cardiovascular outcome trials in type 2 diabetes and the sulphonylurea controversy: Rationale for the active-comparator CAROLINA® trial]Baptist Gallwitz, Sandra Thiemann, Hans-Jürgen Wörle, et al.
The Journal of Maternal-Fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians|October 6, 2005
Pheochromocytoma in a patient with sickle-beta-thalassemiaKarsten Müssig, Marius Horger, Hans-Ulrich Häring, et al.
Acta Diabetologica|August 24, 2011
Contribution of insulin deficiency and insulin resistance to the development of type 2 diabetes: nature of early stage diabetesBaptist Gallwitz, Christof Kazda, Petra Kraus, et al.
Clinical Endocrinology|July 27, 2004
Manifestation of thyroid autoimmunity in patients successfully treated for hypercortisolismKarsten Müssig, Baptist Gallwitz, Hans-Ulrich Häring, et al.
Pageof 13